Research demonstrates Raman technology improves calcium phosphate production from biowaste, suggesting efficiency in mineral conversion.
The sustainable conversion of biogenic waste into high-value materials presents a promising approach for addressing environmental and industrial challenges. This work reports an advancement into antioxidant-enriched phosphate minerals derived from green conversion of biogenic calcium carbonates of crustaceans. We demonstrate the effectiveness of Raman technology in controlling conversion using phosphoric acid treatment. The effects of reaction parameters—including acid stoichiometry, granular size distribution, and thermal treatment at 700 °C and 1200 °C—were systematically evaluated. Raman spectroscopy results validated by X-ray diffraction (XRD) and SEM-EDX analyses revealed mixed-phase minerals monetite, brushite, whitlockite or hydroxylapatite resepectively. Notably, reducing particle size enhanced conversion efficiency by increasing the reactive surface area, while the use of excess phosphoric acid facilitated conversion to monocalcium phosphate and promoted the degradation of the organic matrix. Thermal treatment further altered the product composition: heating at 700 °C produced a whitlockite-rich phase, whereas treatment at 1200 °C shifted the balance toward hydroxylapatite. The synthesized calcium phosphate compounds, including hydroxylapatite, monocalcium phosphate, whitlockite, and brushite hold significant practical utility in biomedical applications (such as bone grafts and dental implants), agriculture, and industrial processing. Moreover, we have proven that by controlling the reaction parameters the final product composition can be tailored according to the specific needs, a greener approach yields brushite, monetite, or monocalcium phosphate while a more energy demanding process including heating to 1200 0C yields a high purity hydroxylapatite. This research offers a sustainable analytical route for producing high-purity calcium phosphate materials from wasted biomaterials, contributing to both bioeconomy as well as scientific innovation.
No takes yet. Share an insight, caveat, or question.
Lazar et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: